Skip to content
10-Q

Quarterly Report

INVIVO THERAPEUTICS HOLDINGS CORP.

0001558370-22-012649

← back to feed
Filed
Aug 8, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 5, 2022 1.39M sh
Shares Diluted Q2 2022 · Jun 30, 2022 1.38M sh
Shares Diluted Q2 2022 · Jun 30, 2021 1.37M sh
Shares Diluted Q2 2022 · Jun 30, 2021 1.28M sh
Cash And Equivalents Q2 2022 · Jun 30, 2022 $13.03M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $19.03M
Current Liabilities Q2 2022 · Jun 30, 2022 $2.41M
Current Liabilities Q2 2022 · Dec 31, 2021 $2.61M
Total Liabilities Q2 2022 · Jun 30, 2022 $3.26M
Total Liabilities Q2 2022 · Dec 31, 2021 $3.66M
Current Assets Q2 2022 · Jun 30, 2022 $13.58M
Current Assets Q2 2022 · Dec 31, 2021 $19.14M
Total Assets Q2 2022 · Jun 30, 2022 $16.07M
Total Assets Q2 2022 · Dec 31, 2021 $21.77M
Eps Diluted Q2 2022 · Jun 30, 2022 −$1.97
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.68
Eps Diluted Q2 2022 · Jun 30, 2021 −$3.55
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$4.94M
Stockholders Equity Q2 2022 · Jun 30, 2021 $23.31M
Stockholders Equity Q2 2022 · Mar 31, 2021 $25.52M
Stockholders Equity Q2 2022 · Dec 31, 2020 $19.19M
Eps Basic Q2 2022 · Jun 30, 2021 −$1.68
Eps Basic Q2 2022 · Jun 30, 2021 −$3.55
Sga Expense Q2 2022 · Jun 30, 2021 $1.38M
Sga Expense Q2 2022 · Jun 30, 2021 $2.59M
Rd Expense Q2 2022 · Jun 30, 2021 $928K
Rd Expense Q2 2022 · Jun 30, 2021 $1.94M
Net Income Q2 2022 · Jun 30, 2021 −$2.31M
Net Income Q2 2022 · Jun 30, 2021 −$4.53M
Net Income Q2 2022 · Mar 31, 2021 −$2.22M
Operating Income Q2 2022 · Jun 30, 2021 −$2.31M
Operating Income Q2 2022 · Jun 30, 2021 −$4.53M